| scholarly article | Q13442814 |
| P50 | author | Cristina Granziera | Q42434014 |
| Jacob M. Hooker | Q52280455 | ||
| P2093 | author name string | Daniel S Albrecht | |
| Marco L Loggia | |||
| P2860 | cites work | In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy | Q41882993 |
| FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus | Q42186446 | ||
| Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammation | Q21135473 | ||
| Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation | Q24564399 | ||
| An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 | Q24599479 | ||
| Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies | Q24642726 | ||
| Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair | Q24644752 | ||
| The methodology of TSPO imaging with positron emission tomography | Q26778370 | ||
| Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation | Q26830874 | ||
| Imaging neuroinflammation in multiple sclerosis using TSPO-PET | Q28084625 | ||
| Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 | ||
| Immune Surveillance of the CNS following Infection and Injury | Q28268038 | ||
| Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry | Q28304258 | ||
| Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study | Q28392661 | ||
| Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases | Q28475810 | ||
| Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 | ||
| Adenosine A(2A) receptor mediates microglial process retraction | Q30488894 | ||
| Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions | Q30502812 | ||
| Magnetic resonance fingerprinting | Q30537825 | ||
| Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain | Q30624704 | ||
| Classic models for dynamic contrast-enhanced MRI. | Q30626277 | ||
| Selective neuronal loss in ischemic stroke and cerebrovascular disease | Q30689231 | ||
| PET in multiple sclerosis | Q30762245 | ||
| Imaging Neuroinflammation - from Bench to Bedside | Q30881154 | ||
| In vivo imaging of neuroinflammation in schizophrenia | Q30966978 | ||
| P-glycoprotein activity in the blood-brain barrier is affected by virus-induced neuroinflammation and antipsychotic treatment | Q42209489 | ||
| Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis | Q42321524 | ||
| Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis. | Q42433959 | ||
| In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester. | Q42490128 | ||
| Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. | Q42500431 | ||
| Physiology: Inflammation links ageing to the brain | Q42806430 | ||
| Animal models of neurological disorders | Q43153020 | ||
| Role of glutamate in neuron-glia metabolic coupling | Q43611488 | ||
| Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem | Q43759373 | ||
| Decreased carbon-11-flumazenil binding in early Alzheimer's disease. | Q44014493 | ||
| The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker | Q44353091 | ||
| Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis | Q44590580 | ||
| Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo | Q45063507 | ||
| Reference and target region modeling of [11C]-(R)-PK11195 brain studies | Q45303765 | ||
| Characterization of PiB binding to white matter in Alzheimer disease and other dementias | Q46151033 | ||
| Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole. | Q46176733 | ||
| 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry | Q46592453 | ||
| Decreased chronic-stage cortical 11C-flumazenil binding after focal ischemia-reperfusion in baboons: a marker of selective neuronal loss? | Q46779682 | ||
| First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine | Q48148245 | ||
| Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats | Q48189477 | ||
| In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia. | Q48200554 | ||
| Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI. | Q48226842 | ||
| Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. | Q48250173 | ||
| Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients | Q48337301 | ||
| Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. | Q48608399 | ||
| In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET. | Q48732605 | ||
| Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation. | Q48774111 | ||
| Simplified reference tissue model for PET receptor studies. | Q48832665 | ||
| Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia. | Q48874149 | ||
| The 18-kDa mitochondrial translocator protein in gliomas: from the bench to bedside. | Q50555831 | ||
| Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model. | Q50942553 | ||
| Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers. | Q53091381 | ||
| Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [¹⁸F]DPA-714. | Q53164158 | ||
| 18F-ML-10, a PET tracer for apoptosis: first human study. | Q53230700 | ||
| Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. | Q54620115 | ||
| Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury | Q57089059 | ||
| Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET | Q70317910 | ||
| Lactate production by human monocytes/macrophages determined by proton MR spectroscopy | Q72059146 | ||
| Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping | Q72334975 | ||
| Reactive gliosis and monoamine oxidase B | Q72728908 | ||
| The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity | Q73119445 | ||
| [Results and consequences of frequent quality control of quantitative clinical 1H-MR-spectroscopy] | Q73630108 | ||
| The upregulation of translocator protein (18 kDa) promotes recovery from neuropathic pain in rats | Q85945587 | ||
| Magnetic resonance spectroscopy of the brain: a review of physical principles and technical methods | Q30982065 | ||
| Nonconventional MRI and microstructural cerebral changes in multiple sclerosis. | Q31015218 | ||
| MRI morphometry in Alzheimer's disease | Q31039994 | ||
| Gray matter alterations in chronic pain: A network-oriented meta-analytic approach | Q33741419 | ||
| Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma | Q33831506 | ||
| Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV. | Q33834306 | ||
| Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition | Q34107466 | ||
| MR spectroscopic studies of the brain in psychiatric disorders | Q34147260 | ||
| Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation | Q34171364 | ||
| Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes | Q34244599 | ||
| Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. | Q34283368 | ||
| Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis | Q34286763 | ||
| Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications | Q34432388 | ||
| Evidence for brain glial activation in chronic pain patients | Q34457857 | ||
| Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis | Q34472457 | ||
| Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome | Q34488155 | ||
| Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System | Q34491870 | ||
| Is there an association between peripheral immune markers and structural/functional neuroimaging findings? | Q34546439 | ||
| Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. | Q34677691 | ||
| Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. | Q34709354 | ||
| Assessing reperfusion with whole-brain arterial spin labeling: a noninvasive alternative to gadolinium | Q34788737 | ||
| Evaluation of excess significance bias in animal studies of neurological diseases | Q34844822 | ||
| A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR | Q34872399 | ||
| Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance | Q34928951 | ||
| Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior | Q34991978 | ||
| Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. | Q35028404 | ||
| Molecular imaging of apoptosis: from micro to macro. | Q35227490 | ||
| Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review | Q35402503 | ||
| Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation. | Q35740284 | ||
| Imaging neuroinflammation? A perspective from MR spectroscopy. | Q35824849 | ||
| Brain tissue compartment density estimated using diffusion-weighted MRI yields tissue parameters consistent with histology | Q35985392 | ||
| Noninvasive molecular imaging of neuroinflammation | Q36079268 | ||
| Enlargement of choroid plexus in complex regional pain syndrome | Q36099117 | ||
| Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study | Q36186141 | ||
| Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography | Q36254332 | ||
| Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography | Q36265825 | ||
| TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology | Q36396082 | ||
| Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms | Q36459054 | ||
| Activity-triggered tetrapartite neuron-glial interactions following peripheral injury | Q36474044 | ||
| Brain nicotinic acetylcholine receptors: native subtypes and their relevance. | Q36550823 | ||
| Heat-Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET. | Q36581653 | ||
| The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging | Q36677808 | ||
| A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation | Q36684216 | ||
| Modulation of inflammation in brain: a matter of fat. | Q36719738 | ||
| Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study. | Q36766806 | ||
| Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference | Q36770873 | ||
| Distribution volume ratios without blood sampling from graphical analysis of PET data | Q36817029 | ||
| Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein | Q36821286 | ||
| Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide | Q36951565 | ||
| In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. | Q36953874 | ||
| Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. | Q36983897 | ||
| Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study. | Q37150330 | ||
| Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain | Q37221310 | ||
| Non-invasive visualization of CNS inflammation with nuclear and optical imaging | Q37317306 | ||
| P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. | Q37364487 | ||
| Labeling monocytes for imaging chronic inflammation. | Q37381650 | ||
| Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future | Q37422795 | ||
| Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders | Q37814088 | ||
| Noninvasive cell-tracking methods | Q37938642 | ||
| Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity | Q38166592 | ||
| Adenosine receptor PET imaging in human brain | Q38245133 | ||
| Astrocyte reactivity and reactive astrogliosis: costs and benefits | Q38257345 | ||
| A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the "post-inflammatory brain syndrome" PIBS. | Q38367319 | ||
| Immune attack: the role of inflammation in Alzheimer disease. | Q38492631 | ||
| The immunomodulatory oligodendrocyte | Q38596122 | ||
| Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke | Q38623025 | ||
| Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein | Q40965410 | ||
| Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy | Q41102314 | ||
| In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke | Q41378245 | ||
| Multinuclear NMR studies on the energy metabolism of glial and neuronal cells | Q41587105 | ||
| Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients | Q41618855 | ||
| P2507 | corrigendum / erratum | Correction to In Vivo Imaging of Human Neuroinflammation | Q88511238 |
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| neuronitis | Q17157137 | ||
| P304 | page(s) | 470-483 | |
| P577 | publication date | 2016-03-17 | |
| P1433 | published in | ACS Chemical Neuroscience | Q2819059 |
| P1476 | title | In Vivo Imaging of Human Neuroinflammation | |
| P478 | volume | 7 |
| Q41556036 | A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of Neuroinflammation |
| Q88246758 | A Systematic Review of Positron Emission Tomography of Tau, Amyloid Beta, and Neuroinflammation in Chronic Traumatic Encephalopathy: The Evidence To Date |
| Q55052878 | Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines. |
| Q48118494 | Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [(11)C]PBR28 study |
| Q55457127 | Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. |
| Q58798995 | Designing Blood-Brain Barrier Models Reproducing Alterations in Brain Aging |
| Q64229066 | Detecting Microglial Density With Quantitative Multi-Compartment Diffusion MRI |
| Q58751451 | Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO |
| Q89397411 | Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis |
| Q47260664 | Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [11C]PBR28 and [18F]FDOPA PET. |
| Q38739510 | Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis. |
| Q58077250 | Extracellular Vesicles in Psychiatry Research in the Context of RDoC Criteria |
| Q90317315 | First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound |
| Q47350689 | Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities |
| Q47574588 | Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment. |
| Q38779574 | In vivo PET imaging of neuroinflammation in Alzheimer's disease. |
| Q51765219 | Inflammation in CNS Neurodegenerative Diseases. |
| Q58793142 | Integrated imaging of [C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy H-MRS in amyotrophic lateral sclerosis |
| Q36392550 | Kinetic modelling of [(11)C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis. |
| Q61455308 | Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics |
| Q92442159 | Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back |
| Q87921341 | Neuroimaging of Pain: Human Evidence and Clinical Relevance of Central Nervous System Processes and Modulation |
| Q61449541 | Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods |
| Q39173756 | Neuroinflammation in Neurodegenerative Disorders-a Review |
| Q50117953 | Neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients. |
| Q92413012 | Neuroinflammation trajectories precede cognitive impairment after experimental meningitis-evidence from an in vivo PET study |
| Q89667084 | Objective Pain Assessment: a Key for the Management of Chronic Pain |
| Q92363662 | PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases |
| Q47688720 | PET Imaging of Human Brown Adipose Tissue with the TSPO Tracer [(11)C]PBR28. |
| Q89642986 | PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan |
| Q41687400 | PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. |
| Q90170194 | PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers |
| Q55240298 | Pharmaceutical iron formulations do not cross a model of the human blood-brain barrier. |
| Q92513980 | Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer's disease |
| Q47938329 | Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts |
| Q49347037 | Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy. |
| Q38790900 | Septic encephalopathy and septic encephalitis. |
| Q90423813 | Teriflunomide Modulates Vascular Permeability and Microglial Activation after Experimental Traumatic Brain Injury |
| Q58575599 | The antidiabetic drug metformin prevents and reverses neuropathic pain and spinal cord microglial activation in male but not female mice |
| Q42656274 | The roles of inflammation and immune mechanisms in Alzheimer's disease |
| Q39271545 | Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis |
| Q96231555 | Traumatic brain injury-related inflammatory projection: beyond local inflammatory responses |
| Q38628034 | Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model. |
Search more.